The Safest Way To Start Trading Is Here!
One look at Wall Street right now and anyone can tell: it’s a mess! But new trades can get an edge with “Options Trading Made Easy” by trading champion Chuck Hughes, the best guide to options trading in the modern market.

Start with a small investment today and see where you can go!

Get your copy now!
>>>

NYR Insider Trading (Nyrada)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): A$0.00
Insider Selling (Last 12 Months): A$0.00

Nyrada Insider Trading History Chart

This chart shows the insider buying and selling history at Nyrada by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Nyrada Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/13/2020 01:00 AM ET

This chart shows the closing price history over time for NYR up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Trading Isn’t Getting Easier–But Options Just Did!
Options trading expert and trading champion Chuck Hughes has done it again with his guide, “Options Trading Made Easy”!

Made for new traders, this guide explains options–plus the consistent profits you could make–in easy to understand terms.

Don’t keep waiting for it to get easier–get the e-book here!
>>>

Nyrada Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/29/2021Ruediger WeselohInsiderIssued100,000A$0.26A$26,000.00
2/23/2021Marcus FramptonInsiderBuy25,000A$0.36A$8,925.00
9/10/2020John MooreInsiderBuy32,500A$0.21A$6,825.00
4/23/2020John MooreInsiderBuy35,000A$0.17A$5,880.00
See Full Table
Trading Isn’t Getting Easier–But Options Just Did!
Options trading expert and trading champion Chuck Hughes has done it again with his guide, “Options Trading Made Easy”!

Made for new traders, this guide explains options–plus the consistent profits you could make–in easy to understand terms.

Don’t keep waiting for it to get easier–get the e-book here!
>>>

SEC Filings (Institutional Ownership Changes) for Nyrada (ASX:NYR)

Nyrada Inc., a pre-clinical stage drug development company, engages in the development of small molecule drugs for cardiovascular, neurodegenerative, and chronic inflammatory diseases. Its products in the drug development stage include PCSK9 inhibitor for the treatment of high blood LDL-cholesterol levels in patients poorly responsive to or unable to take statin drugs; NYR-BI01, a neuroprotectant drug, to reduce the disability in patients with ischaemic stroke and traumatic brain injury; a drug to treat pain associated with peripheral nerve damage; and a drug to treat autoimmune diseases, such as psoriasis. The company has collaboration with Walter Reed Army Institute of Research and University of New South Wales, Sydney for advancement of preclinical neuroprotection compound for traumatic brain injury. Nyrada Inc. was incorporated in 2017 and is based in Gordon, Australia.
Read More on Nyrada

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

65,000 shs

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Nyrada?

Nyrada's top insider investors include:
  1. John Moore (Insider)
  2. Marcus Frampton (Insider)
  3. Ruediger Weseloh (Insider)
Learn More about top insider investors at Nyrada.
Trading Isn’t Getting Easier–But Options Just Did!
Options trading expert and trading champion Chuck Hughes has done it again with his guide, “Options Trading Made Easy”!

Made for new traders, this guide explains options–plus the consistent profits you could make–in easy to understand terms.

Don’t keep waiting for it to get easier–get the e-book here!
>>>